ArticleAnnals of surgical oncology2022

ASO Author Reflections: NADPH Oxidase 2 has Potential as a Therapeutic Target for Esophageal Squamous Cell Carcinoma.

Hiroki Shimizu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.